| Characteristic | Export value in thousand euros |
|---|---|
| Switzerland | 48,534,169 |
| Germany | 42,122,728 |
| Ireland | 41,052,292 |
| Belgium | 39,130,256 |
| Netherlands | 11,253,946 |
| Italy | 10,913,766 |
| Austria | 9,309,593 |
| France | 8,751,893 |
| Spain | 6,830,850 |
| United Kingdom | 6,388,217 |
| Sweden | 5,366,826 |
| Denmark | 4,349,057 |
| Hungary | 2,274,799 |
| Poland | 1,343,357 |
| Slovenia | 1,300,203 |
| Czechia | 592,964 |
| Croatia | 321,878 |
| Lithuania | 256,713 |
| Russian Federation | 160,830 |
| Finland | 108,066 |
| Slovakia | 83,549 |
| Norway | 81,450 |
| Greece | 64,214 |
| Portugal | 63,666 |
| Ukraine | 43,337 |
| Iceland | 28,372 |
| Bulgaria | 24,364 |
| Romania | 23,171 |
| Latvia | 22,087 |
| Estonia | 9,039 |
| Serbia | 6,082 |
| Luxembourg | 3,656 |
| Macedonia, North | 1,797 |
| Belarus | 1,454 |
| Moldova, Republic of | 1,431 |
| Bosnia and Herzegovina | 563 |
| Cyprus | 241 |
| Albania | 37 |
| Faroe Islands | 2 |
| Montenegro | 1 |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
More information
Region
Europe
Survey time period
2023
Supplementary notes
Prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products.
Product code 30 'Pharmaceutical products'. Subcode '3002.
Figures calculated by International Trade Centre (ITC) based on UN Comtrade statistics.
Figures have been rounded.
Release date given is the date of access (the database is constantly updated by the source).
Citation formats
